Abstract

We recently synthesized novel glucose-conjugated dual factor Xa (fXa) and thrombin (fIIa) inhibitors 3, bearing 5-chlorothien-2-yl and 1-isopropylpiperidine moieties as binders of the S1 and S3/S4 enzymes’ pockets, respectively, which showed potential for use in the treatment of thrombotic diseases. In particular, the β-d-glucosyl-bearing derivative proved to be a competitive inhibitor with high potency against fXa (Ki = 0.09 nM) and fIIa (Ki = 100 nM), and in vitro/ex vivo micromolar anticoagulant potency.1 Despite the narrower binding site groove of fIIa, the inhibitory potency of the glucosyl derivative, compared to the parent glucosyl-lacking compound 1, increases against fIIa (110-fold) much more than against fXa (7-fold). Experimental deconstruction of the most potent inhibitor molecule into smaller fragments, synthesized and tested, provided us with significant insights into the enzymes’ affinity contributions of the P1 and P3/P4 moieties, and a C3-alkyl-linked -d-glucose fragment (PG). To understand the inhibitors’ binding modes to fIIa, the crystal structures of human thrombin in complex with two glucose-based compounds were solved (pdb codes: 4NZE and 4N3L), and the crystallographic results will be presented and discussed.

Autore Pugliese

• Altomare Cosimo Damiano , De Candia Modesto

Tutti gli autori

• ALTOMARE C.D.;DE CANDIA M.

Titolo volume/Rivista

Non Disponibile

Anno di pubblicazione

2014

ISSN

Non Disponibile

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile